Light Science Technologies Holdings PLC (AIM:LST) earlier this week said its Injectaclad product has passed new testing to confirm a 50-year lifespan, meeting ASTM F1980 standards.
The company told investors that this milestone doubles the previous 25-year rating and provides long-term assurance for building safety stakeholders.
The company said the result gives Injectaclad a competitive edge, with some rival products offering only 15 to 20 years of durability.
Chief executive Simon Deacon joined the Proactive to talk about it in more detail.
Light Science Technologies’ Injectaclad saw a major milestone – ICY
